You are here

neutropenia

FDA shoots down Spectrum's neutropenia drug, citing manufacturing issues

Endpoints

Fri, 08/6/21 - 11:06 am

Spectrum Pharmaceuticals

Spectrum's Rolontis hits another setback as FDA faces COVID-19 plant inspection backlog

Fierce Pharma

Tue, 10/27/20 - 11:55 am

Spectrum Pharmaceuticals

Teva’s Granix Gets FDA Approval for Expanded Indication

Market Realist

Tue, 08/7/18 - 11:31 am

Teva Pharmaceutical

Spectrum's Rolontis Meets Primary Endpoint in Ph III Study for Neutropenia

CP Wire

Fri, 06/29/18 - 10:07 am

Spectrum Pharmaceuticals

Novartis copy of Amgen biotech drug shows similar efficacy-study

Yahoo/Reuters

Mon, 12/8/14 - 08:24 am

Teva rises on cancer updates

Globes, Israel

Sun, 08/11/13 - 11:17 am

prostate cancer

metastatic castration-resistant prostate cancer

chemotheraphy-induced neutropenia

Teva Announces FDA Grants Approval for Tbo-filgrastim for the Treatment of Chemotherapy-Induced Neutropenia

Yahoo

Thu, 08/30/12 - 09:57 am

Teva Pharmaceuticals

Teva Announces Progress of Biologic Investigational Drugs Evaluated to Treat Neutropenia in Breast Cancer Patients Undergoing Chemotherapy

Pipeline Review

Sat, 06/30/12 - 04:41 pm

Teva Pharmaceuticals

lipegfilgrastim

Teva reports positive Phase III blood disease trial results

Globes, Israel

Mon, 06/6/11 - 11:10 am

Teva Pharmaceuticals

lipegfilgrastim

FDA delays ruling on Teva version of Amgen drug

Yahoo/AP

Fri, 10/1/10 - 12:16 pm

Teva Pharmaceuticals